| 2024/07/16 17:20:45 | |
|---|---|
| Price | |
| 17.092 USD | |
| Difference | 1.08% (0.18) |
General attributes
| ISIN | JP3546800008 |
| Symbol | 4543 |
| Exchange | FINRA other OTC Issues |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 23,768 EUR |
| Benchmark | NIKKEI 225 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 17.078 USD |
| High | 17.092 USD |
| Low | 16.89 USD |
| Close (prev. day) | 16.91 USD |
| VWAP | 17.051848 USD |
| Volume (pcs) | 1,177 |
| Trading volume | 20,236.69 |
| Number of trades | 17 |
| Last size | 133 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: TERUMO CORP |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/07/16 17:20:45 | |
|---|---|
| Price | |
| 17.092 USD | |
| Difference | 1.08% (0.18) |
General attributes
| ISIN | JP3546800008 |
| Symbol | 4543 |
| Exchange | FINRA other OTC Issues |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 23,768 EUR |
| Benchmark | NIKKEI 225 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 17.078 USD |
| High | 17.092 USD |
| Low | 16.89 USD |
| Close (prev. day) | 16.91 USD |
| VWAP | 17.051848 USD |
| Volume (pcs) | 1,177 |
| Trading volume | 20,236.69 |
| Number of trades | 17 |
| Last size | 133 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +0.83% | +9.80% | -11.78% |
| Perf (abs.) | +0.14 | +1.53 | -2.28 |
| Beta | 0.91 | 0.97 | 0.99 |
| Volatility | 48.12 | 44.82 | 37.23 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 16.989 USD (1,064) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 16.675 USD (1,911) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 17.392 USD (1,812) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 16.096 USD (4,224) |
| YTD High | date | 19.843 USD (2024/03/04) |
| YTD Low | date | 15.000 USD (2024/06/27) |
| 52 Weeks High | date | 19.843 USD (2024/03/04) |
| 52 Weeks Low | date | 12.482 USD (2023/10/13) |
All listings for TERUMO CORP
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/07/16 | 22:26 | 16.10 EUR | 0.00 | 1 |
| Tokyo Stock Exchange | 2024/07/16 | 08:00 | 2,759.00 JPY | 52.34 | 3,830 |
| Stuttgart | 2024/07/17 | 08:17 | 16.20 EUR | 0.00 | 1 |
| Munich | 2024/07/17 | 08:18 | 16.30 EUR | 0.00 | 1 |
| Hanover | 2024/07/17 | 08:06 | 16.30 EUR | 0.00 | 1 |
| Frankfurt | 2024/07/17 | 08:07 | 16.30 EUR | 0.00 | 1 |
| FINRA other OTC Issues | 2024/07/16 | 17:20 | 17.092 USD | 0.02 | 17 |
| Duesseldorf | 2024/07/17 | 08:10 | 16.20 EUR | 0.00 | 1 |
| Berlin | 2024/07/17 | 08:19 | 16.30 EUR | 0.00 | 1 |
Company Logo
Contact Details
| TERUMO CORP. |
| - - |
| 2-44-1 Hatagaya, Shibuya-Ku - 151-0072 Tokyo |
| Telefon: +81-3-3374-8111 |
| Fax: + |
| E-mail: kouhou_terumo01@terumo.co.jp |
PDF Downloads
| Company report: TERUMO CORP | |
Company Profile
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan. |
Members of Management Board
| Shinjiro Sato | Chairman of Managing Board |
| Antoinette Gawin | Member of Executive Committee |
| Fumihisa Hirose | Member of Executive Committee |
| Hiraku Samejima | Member of Executive Committee |
| Kazunori Hirose | Member of Executive Committee |
| Norimasa Kunimoto | Member of Executive Committee |
| Shoji Hatano | Member of Executive Committee |
| Toshiaki Takagi | Member of Executive Committee |
| Toshihiko Osada | Member of Executive Committee |
Board of directors
| Toshiaki Takagi | Chairman of Supervisory Board |
| Hidenori Nishi | Member of Supervisory Board |
| Keiya Ozawa | Member of Supervisory Board |
| Kyo Nishikawa | Member of Supervisory Board |
| Masaichi Nakamura | Member of Supervisory Board |
| Shinjiro Sato | Member of Supervisory Board |
| Shouji Hatano | Member of Supervisory Board |
| Soichiro Uno | Member of Supervisory Board |
| Takanori Shibazaki | Member of Supervisory Board |
| Yukiko Kuroda | Member of Supervisory Board |